2017-12-162017-12-162016-042169-8287http://hdl.handle.net/2133/10239We report here the draft genome sequence of a NDM-1-producing Acinetobacter bereziniae clinical strain, HPC229. This strain harbors both plasmid and chromosomal resistance determinants towards different β-lactams and aminoglycosides as well as several types of multidrug efflux pumps, most likely representing an adaptation strategy for survival under different environments.application/pdfe00117-16engopenAccessAcinetobacter BereziniaeNDM B-lactamaseCarbapenem ResistanceAmerican Society for MicrobiologyBrovedan, MarcoMarchiaro, Patricia M.Morán-Barrio, JorgelinaRevale, SantiagoCameranesi, MarcelaBrambilla, LucianoViale, Alejandro M.Limansky, Adriana S.Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)